Inventiva S.A. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE6-KInventiva S.A.IVEVFOct 8

   Inventiva S.A. announces abstracts for AASLD meeting

   • Presented three abstracts at AASLD The Liver Meeting 2026
   • Preclinical data showed lanifibranor affects multiple hepatic cell pathways
   • Phase 3 trial results expected in Q4 2026
2. ROUTINE6-KInventiva S.A.IVEVFSep 28

   Foreign issuer report

3. ROUTINE6-KInventiva S.A.IVEVFSep 3

   Foreign issuer report

4. ROUTINE6-K/AInventiva S.A.IVEVFJul 30

   Foreign issuer report (amended)

5. ROUTINE6-KInventiva S.A.IVEVFJul 29

   Foreign issuer report

6. ROUTINE6-KInventiva S.A.IVAJul 9

   Foreign issuer report

7. ROUTINE6-KInventiva S.A.IVEVFJul 6

   Foreign issuer report

8. ROUTINE6-KInventiva S.A.IVEVFJun 12

   Foreign issuer report

9. ROUTINE6-KInventiva S.A.IVEVFJun 12

   Foreign issuer report

10. ROUTINE6-KInventiva S.A.IVEVFJun 9

    Foreign issuer report

11. ROUTINE6-KInventiva S.A.IVEVFJun 3

    Foreign issuer report

12. ROUTINE6-KInventiva S.A.IVEVFJun 3

    Foreign issuer report

13. ROUTINE424B5Inventiva S.A.IVEVFJun 2

    2 structured-note prospectuses

    Securities offering

    Show all 2

    • 424B5Securities offeringJun 2
    • FWPSecurities offeringJun 2
14. ROUTINEF-3ASRInventiva S.A.IVEVFJun 2

    Securities offering

15. ROUTINE6-KInventiva S.A.IVEVFMay 26

    Foreign issuer report

16. ROUTINE6-KInventiva S.A.IVEVFMay 22

    Foreign issuer report

17. ROUTINESCHEDULE 13G/AInventiva S.A.IVEVFMay 15

    Ownership stake disclosure by Deep Track Capital, LP (amended)

    Deep Track Capital, LP, filed by

18. ROUTINE6-KInventiva S.A.IVEVFApr 22

    Foreign issuer report

19. NOTABLE20-FInventiva S.A.IVEVFApr 8

    Annual report

20. NOTABLESCHEDULE 13D/AInventiva S.A.IVEVFApr 1

    Ownership stake disclosure by New Enterprise Associates 17, L.P. (amended)

    New Enterprise Associates 17, L.P., filed by

21. ROUTINE6-KInventiva S.A.IVEVFMar 30

    Foreign issuer report

22. ROUTINESCHEDULE 13G/AInventiva S.A.IVEVFFeb 17

    Ownership stake disclosure by Andera Partners (amended)

    Andera Partners, filed by

23. ROUTINESCHEDULE 13G/AInventiva S.A.IVEVFFeb 17

    2 13G filings

    Ownership stake disclosure by Crossover I Sofinnova (amended)

    Show all 2

    • SCHEDULE 13G/AOwnership stake disclosure (amended)Feb 17
    • SCHEDULE 13G/AOwnership stake disclosure (amended)Feb 17

    Crossover I Sofinnova, filed by

24. ROUTINE6-KInventiva S.A.IVEVFFeb 17

    Foreign issuer report

25. ROUTINESCHEDULE 13G/AInventiva S.A.IVEVFFeb 13

    Ownership stake disclosure by EVENTIDE ASSET MANAGEMENT, LLC (amended)

    EVENTIDE ASSET MANAGEMENT, LLC, filed by

26. ROUTINESCHEDULE 13GInventiva S.A.IVEVFJan 30

    Ownership stake disclosure by Deep Track Capital, LP

    Deep Track Capital, LP, filed by

27. ROUTINE6-KInventiva S.A.IVEVFNov 28, 2025

    Foreign issuer report

28. NOTABLESCHEDULE 13D/AInventiva S.A.IVEVFNov 20, 2025

    Inventiva S.A. filed SCHEDULE 13D/A

    • Form Type: SCHEDULE 13D/A
    • Filing Date: 2025-11-19

    Samsara BioCapital, L.P., filed by

29. NOTABLESCHEDULE 13D/AInventiva S.A.IVEVFNov 19, 2025

    Inventiva S.A. filed SCHEDULE 13D/A

    • Form Type: SCHEDULE 13D/A
    • Filing Date: 2025-11-19

    BIOTECHNOLOGY VALUE FUND L P, filed by

30. ROUTINESCHEDULE 13G/AInventiva S.A.IVEVFNov 14, 2025

    Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)

    PERCEPTIVE ADVISORS LLC, filed by

31. ROUTINESCHEDULE 13G/AInventiva S.A.IVEVFNov 14, 2025

    Ownership stake disclosure by GREAT POINT PARTNERS LLC (amended)

    GREAT POINT PARTNERS LLC, filed by

32. ROUTINE6-KInventiva S.A.IVEVFNov 13, 2025

    Inventiva S.A. (IVEVF) filed a Form 6-K reporting on the company's recent participation in a major industry conference, where it presented updates on its pipeline of novel therapeutic candidates for rare diseases.

33. ROUTINE424B5Inventiva S.A.IVEVFNov 13, 2025

    Inventiva S.A. (IVEVF) filed a 424B5 prospectus supplement to offer 38,961,038 American Depositary Shares (ADSs) at $3.85 per ADS, with each ADS representing one ordinary share.

34. ROUTINESCHEDULE 13G/AInventiva S.A.IVEVFNov 13, 2025

    Inventiva S.A. (IVEVF) filed a Schedule 13G/A, disclosing changes in its ownership position in the company. This filing indicates that a related party has crossed the 5% ownership threshold, which may signal a shift in the company's shareholder structure and could impact…

    Yiheng Capital Management, L.P., filed by

35. ROUTINEFWPInventiva S.A.IVEVFNov 13, 2025

    Inventiva S.A. (IVEVF) announced the pricing of an upsized public offering of approximately $150 million. This filing discloses the details of this capital raise, which will provide the company with additional funds to support its ongoing business operations and strategic…

36. ROUTINEFWPInventiva S.A.IVEVFNov 12, 2025

    Securities offering

37. ROUTINE424B5Inventiva S.A.IVEVFNov 12, 2025

    Securities offering

38. ROUTINE6-KInventiva S.A.IVEVFNov 7, 2025

    Foreign issuer report

39. ROUTINE6-KInventiva S.A.IVEVFNov 6, 2025

    Foreign issuer report

40. ROUTINE6-KInventiva S.A.IVEVFNov 6, 2025

    Foreign issuer report

41. ROUTINE6-KInventiva S.A.IVEVFOct 30, 2025

    Foreign issuer report

Older filings on EDGAR